semaglutide cause blindness causing A new study suggests patients taking — the active ingredient in Ozempic and Wegovy — may be at higher risk of developing an eye condition that can blindness Understanding Semaglutide and Its Impact

*Correspondence: Erin E

Proper needles help deliver measured water volumes into peptide vials

Clinical trials show that nausea typically lasts about 8 days, while vomiting subsides within 2 days, so these symptoms often improve as your body adjusts

SELECT Trial: The Evidence for CV Coverage The SELECT trial (published in NEJM, November 2023) demonstrated that Wegovy reduces cardiovascular events: [27] 20% reduction in major adverse cardiovascular events (MACE) Includes heart attacks, strokes, and cardiovascular death 17,604 participants followed for ~3.3 years All participants had established cardiovascular disease plus obesity/overweight Typical Plan Coverage Criteria for CV Indication Medicare plans that cover Wegovy for cardiovascular risk reduction typically require: Clinical Criteria Established cardiovascular disease (prior heart attack, stroke, or peripheral artery disease) BMI (body mass index) 27 kg/m No Type 2 diabetes (or T2D not adequately controlled) Concurrent lifestyle modifications (diet and exercise) Required Documentation Cardiology records documenting established CVD Current BMI (height and weight within last 30 days) Letter of Medical Necessity from cardiologist or primary care provider Documentation of lifestyle modification attempts ICD-10 Codes for CV vs

These side effects often lessen with time